Summary
Disopyramide, a Class la antiarrhythmic drug, is clinically used as a racemic mixture; R(−)disopyramide and S(+)disopyramide. The major metabolite in man is desisopropyldisopyramide: R(−)desisopropyl-disopyramide and S(+)desisopropyldisopyramide. The effects of the four compounds were compared on the electrophysiological characteristics of the guinea-pig papillary muscle using the standard microelectrode technique. At an external K+ concentration of 5.4 mmol/l and a stimulation frequency of 1 Hz, S(+)disopyramide (20 μmol/l) increased action potential duration (APD) by more than 18%, while it was diminished by 6% in the presence of R(−)disopyramide. Resting membrane potential amounted to −87.1 ± 0.5 mV (n = 14) and −85.6 ± 1.2 mV (n = 10), respectively. Also a small but significant difference in effect on the maximal rate of depolarization was observed, R(−)disopyramide being more potent, related with a slower recovery of the maximal rate of depolarization.
The enantiomers of the metabolite appeared to be three times less potent than those of the parent drug in their effect on the maximal rate of depolarization. The characteristics of the enantiomers of the metabolite correlated with those of the parent drug: also the R(−)-enantiomer was more potent in decreasing the maximal rate of depolarization and caused more shortening of the action potential than the S(+)enantiomer.
Time constants for onset and recovery of/from rate dependent block of the maximal rate of depolarization were dependent upon the external K+ concentration, both for the enantiomers of the parent drug and those of the metabolite. Onset slowed down while recovery accelerated when external K+ was increased. Time constants were lower for the metabolite.
When stimulation interval was shortened, the effect on the maximal rate of depolarisation increased. Only for the metabolite statistical significant stereoselective differences were observed at all stimulation intervals. The effects on the action potential duration were dependent upon stimulation interval; for all enantiomers the action potential duration tended to be relatively (% of control) higher at short stimulation intervals than at large stimulation intervals. The effect on the maximal rate of depolarization was also voltage dependent, but no significant differences were observed between the enantiomers, for the parent drug as well as for the metabolite.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aitio ML, Vuorenmaa T (1980) Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction? Br J Clin Pharmacol 9:149–152
Baines MW, Davies JE, Kellett DN, Munt PL (1976) Some pharmacological effects of disopyramide and a metabolite. J Int Med res 4 [Suppl 1]:5–7
Bredesen JE, Kierulf P (1984) Relationship between α1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Br J Clin Pharmacol 18:779–784
Burke TR, Nelson WL, Mangion M, Hite GJ, Mokler CM, Ruenitz PC (1980) Resolution, absolute configuration, and antiarrhythmic properties of the enantiomers of disopyramide, 4-(diisopropylamino)-2-(2-pyridyl)-2-phenylbutyramide. J Med Chem 23:1044–1048
Campbell TJ (1983) Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br J Pharmacol 80:33–40
Carmeliet E (1988) Activation block and trapping of penticainide, a disopyramide analogue, in the Na+ channel of rabbit cardiac Purkinje fibers. Circ Res 63:50–60
Carmeliet E, Saikawa T (1982) Shorterning of the action potential and reduction of the pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac Purkinje fibers. An effect on Na or K currents? Circ Res 50:257–272
Corabceuf E, Deroubaix E, Escande D, Coulombe A (1988) Comparative effects of three class I antiarrythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. Cardiovasc Res 22:375–384
Courtney KR (1980) Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol 12:1273–1286
Dubray C, Boucher M, Paire M, Pinatel H, Duchêne-Marullaz P (1986) Comparative effects of disopyramide and its mono-N-dealkylated metabolite in conscious dogs with chronic atrioventricular block: plasma concentration-response relationships. J Cardiovasc Pharmacol 8:1229–1234
Giacomini KM, Cox BM, Blaschke JF (1980) Comparative anticholinergic potencies of R- and S-disopyramide in longitudinal muscle strips from guinea-pig ileum. Life Sci 27:1191–1197
Grant AM, Marshall RJ, Ankier SI (1978) Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle. Eur J Pharmacol 49:389–394
Gruber R, Carmeliet E (1989) The activation gate of the sodium channel controls blockade and deblockade by disopyramide in rabbit Purkinje fibres. Br J Pharmacol 97:41–50
Huang JD, Oie S (1983a) Comparison of electrocardiographic response and disposition of R- and S-disopyramide in the rabbit. Res Commun Chem Pathol Pharmacol 41:227–241
Huang JD, Oie S (1983b) Effect of intra-individual change in serum protein binding on the pharmacological response of R- and S-disopyramide in the rabbit. Res Commun Chem Pathol Pharmacol 41:243–253
Julian IDG (1988) The arrythmogenic effects of antiarrhythmic drugs. Eur Heart J 9 [Suppl]:1–4
Karim A, Ranney RE, Kraychy S (1972) Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate. J Pharmacol Sci 61:888–893
Kidwell GA, Schaal SF, Muir III WW (1987) Stereospecifc effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine. J Cardiovasc Pharmacol 9:276–284
Kidwell GA, Lima JJ, Schaal SF, Muir III WW (1989) Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model. J Cardiovasc Pharmacol 13:644–655
Kojima M (1981) Effects of disopyramide on transmembrane action potentials in guinea-pig papillary muscles. Eur J Pharmacol 69:11–24
Kojima M, Ban T, Sada H (1982) Effects of disopyramide on the maximum rate of rise of action potential (\.Vmax) in guinea-pig papillary muscles. Jp J Pharmacol 32:91–102
Lima JJ, Boudoulas H (1987) Stereoselective effects of disopyramide enantiomers in humans. J Cardiovasc Pharmacol 9:594–600
Mirro MJ, Manalan AS, Baily JC, Watanabe AM (1980) Anticholinergic effects of disopyramide and quinidine on guinea-pig myocardium. Mediation by direct muscarinic receptor blockade. Circ Res 47:855–865
Mirro MJ, Watanabe AM, Bailey JC (1981) Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry. Circ Res 48: 867–874
Nelson WL, Sneed CK, Giacomini JC, Stauss J, Blaschke TF, Cox BM (1981) Synthesis and anticholinergic properties of the enantiomers of 4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide. J Med Chem 24:614–617
Pedersen LE, Bonde J (1985) Displacement of disopyramide from human plasma proteins. Acta Pharmacol et Toxicol 57:223–226
Pollick C, Giacomini KM, Blaschke TF, Nelson WL, Turner-Tamiyasu K, Briskin V, Popp RL (1982) The cardiac effects of d- and I-disopyramide in normal subjects: a noninvasive study. Circulation 66:447–453
Sheldon RS, Cannon NJ, Duff HJ (1987) A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res 61:492–497
Sheu SS, Lederer WJ (1985) Lidocaine's negative inotropic and antiarrhythmic actions. Dependence on shortening of action potential duration and reduction of intracellular sodium activity. Circ Res 57:578–590
Vanhoutte F, Carmeliet E, Vereecke J, Verbeke N (1988) Stereoselective electrophysiological effects of disopyramide. Pflügers Arch 412: S45 (abstr)
Varro A, Nakaya Y, Elharrar V, Surawicz B (1986) Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 8:178–185
Yeh JZ, TenEick R (1987) Molecular and structural basis of resting and use dependent block of sodium current defined using disopyramide analogues. Biophys J 51:123–135
Author information
Authors and Affiliations
Additional information
Send offprint requests to N. Verbeke at the above address
Rights and permissions
About this article
Cite this article
Vanhoutte, F., Vereecke, J., Carmeliet, E. et al. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle. Naunyn-Schmiedeberg's Arch Pharmacol 344, 662–673 (1991). https://doi.org/10.1007/BF00174750
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00174750